États-Unis · Plateformes & données · MarketBeat

Edwards Lifesciences Highlights PASCAL, TAVR Data Showing Patient Benefits

Publié par MarketBeat · États-Unis il y a 1 h

Edwards Lifesciences (NYSE:EW) highlighted new clinical data for its transcatheter tricuspid repair and transcatheter aortic valve replacement programs, including results from the…

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Edwards Lifesciences Highlights PASCAL, TAVR Data Showing Patient Benefits

À lire aussi

MSA Safety beats top-line estimates; reaffirms FY26 outlook

Kosmos Energy (KOS) Q3 2026 Earnings Call Transcript

Australian, Chinese airline stocks jump as oil prices plunge more than 7%

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Stock market after midterm elections: What S&P 500 history shows

Bolak Approves KRW 1 Billion Treasury-Share Trust Agreement

Edwards Lifesciences Highlights PASCAL, TAVR Data Showing Patient Benefits

Partager

À lire aussi

MSA Safety beats top-line estimates; reaffirms FY26 outlook

Kosmos Energy (KOS) Q3 2026 Earnings Call Transcript

Australian, Chinese airline stocks jump as oil prices plunge more than 7%

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Stock market after midterm elections: What S&P 500 history shows

Bolak Approves KRW 1 Billion Treasury-Share Trust Agreement